Orphagenix,a Small Biotech Firm,avoids Head-To-Head Competition with Large Pharmaceutical Companies

Multiple Choice

Orphagenix,a small biotech firm,avoids head-to-head competition with large pharmaceutical companies by developing orphan drugs to target diseases that affect fewer than 200,000 people.This is an example of which of Porter's generic strategies?

A) differentiation
B) cost leadership
C) differentiation focus
D) competitive advantage
E) cost focus